ESTUDOS

CLÍNICOS

Conheça alguns os estudos clínicos que tiveram envolvimento da Science Valley:

TRATAMENTO

MICHELLE

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy

ClinicalTrials.gov Identifier: 
NCT04662684

SAIBA +    BAIXE O ESTUDO

  

 

TRATAMENTO

STRUCK TRIAL

Survival Trial Using CytoKines 

ClinicalTrials.gov Identifier: 
NCT04724629

SAIBA +

 

TRATAMENTO

BTK

Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19

ClinicalTrials.gov Identifier:
NCT04528667

SAIBA +

 

TRATAMENTO

COMET-ICE

VIR-7831 for the Early Treatment of COVID-19 in Outpatients

ClinicalTrials.gov Identifier: 
NCT04545060

SAIBA +

 

VACINA

CLINERGY

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19)

ClinicalTrials.gov Identifier:
NCT04510207

SAIBA +

 

VACINA

CLOVER

Clostridium Difficile Vaccine Efficacy Trial

ClinicalTrials.gov Identifier:
NCT03090191

SAIBA +

 

PORTFÓLIO ESTRATÉGICO

VALERIA

Efficacy and safety of rivaroxaban 10 mg once daily versus enoxaparin 40 mg once daily for prophylaxis of venous thromboembolism in gynecological cancer surgery.

ClinicalTrials.gov Identifier:  
em andamento

PORTFÓLIO ESTRATÉGICO

AGRIPPA

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients

ClinicalTrials.gov Identifier: 
NCT04229264

SAIBA +